| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 59.00× | 59.00× | 54.25× | 52.53× | 48.59× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.55× | 3.44× | 2.60× | 1.34× | 2.88× | ||
| 0.66× | 0.66× | 0.74× | 0.84× | 1.03× | ||
| 1.23× | 1.23× | 1.28× | 0.86× | 0.90× | ||
| 0.65× | 0.65× | 0.67× | 0.63× | 0.58× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 48.59 | 52.53 | 54.25 | 59.00 | 59.00 | |
| Working Capital Turnover | 2.88 | 1.34 | 2.60 | 3.44 | 3.55 | |
| Asset Turnover | 1.03 | 0.84 | 0.74 | 0.66 | 0.66 | |
| Cash Conversion (CFO/Net Income) | 0.90 | 0.86 | 1.28 | 1.23 | 1.23 | |
| CFO/EBITDA | 0.58 | 0.63 | 0.67 | 0.65 | 0.65 |